Peng Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peng Deng has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Bin Sun
College of Chemistry, Chemical Engineering and Materials Science, Collaborative Innovation Center of Functionalized Probes for Chemical Imaging, Key Laboratory of Molecular and Nano Probes, Ministry of Education, Shandong Normal University, Jinan, China
3 shared publications- Lizeng Peng
Key Laboratory of Agro-Products Processing Technology of Shandong Province, Key Laboratory of Novel Food Resources Processing Ministry of Agriculture, Institute of Food & Nutrition Science and Technology, Shandong Academy of Agricultural Sciences, Jinan 250100, China
3 shared publications Xiaofei Liu
Jinan AISI Pharmaceutical Technology Co., Ltd., Jinan, China
3 shared publications- Chune Peng
Key Laboratory of Agro-Products Processing Technology of Shandong Province, Key Laboratory of Novel Food Resources Processing Ministry of Agriculture, Institute of Food & Nutrition Science and Technology, Shandong Academy of Agricultural Sciences, Jinan, China
2 shared publications - Lin Shi
Shandong First Med Univ, Dept Ultrasound Diag, Shandong Prov Hosp, Jinan, Peoples R China
2 shared publications Longfei Mao
Shandong Acad Agr Sci, Inst Agrofood Sci & Technol, Key Lab Agroprod Proc Technol Shandong Prov, Key Lab Novel Food Resources Proc,Minist Agr, Jinan 250100, Peoples R China
2 shared publications
Latest Publications
- 1 September 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (9) , 1751-1761
Biological Evaluation and Antitumor Activity of Dolutegravir Derivatives Containing a 1,2,3-Triazole Linker
1,2,3-Triazole moieties with various substituent groups were introduced into the structure of dolutegravir, yielding numerous novel derivatives. These compounds exhibited excellent inhibitory activity against a range of tumor cells, including KYSE30, KYSE140, NE3, AGS, MiaPaCa2, and SKOV3 cells. Most of the compounds exhibited potent effects on MiaPaCa2 cells. Specifically, compounds 4b, 4e, 4f, and 4h demonstrated promising inhibitory activities against MiaPaCa2 cells, with IC50 values of 0.86±0.35, 1.01±0.27, 1.69±0.53, and 1.17±0.37 μM, respectively. Additionally, compounds 4b, 4e, 4f, and 4h induced apoptosis in MiaPaCa2 cells, and compounds 4e, 4f, and 4h induced cell cycle arrest in the G2/M phase. These findings suggest that dolutegravir derivatives are promising candidates for treating MiaPaCa2 tumors.
- 1 September 2025
- Published by Pleiades Publishing Ltd in Russian Journal of Organic Chemistry
- Vol. 61 (9) , 1751-1761
Biological Evaluation and Antitumor Activity of Dolutegravir Derivatives Containing a 1,2,3-Triazole Linker
1,2,3-Triazole moieties with various substituent groups were introduced into the structure of dolutegravir, yielding numerous novel derivatives. These compounds exhibited excellent inhibitory activity against a range of tumor cells, including KYSE30, KYSE140, NE3, AGS, MiaPaCa2, and SKOV3 cells. Most of the compounds exhibited potent effects on MiaPaCa2 cells. Specifically, compounds 4b, 4e, 4f, and 4h demonstrated promising inhibitory activities against MiaPaCa2 cells, with IC50 values of 0.86±0.35, 1.01±0.27, 1.69±0.53, and 1.17±0.37 μM, respectively. Additionally, compounds 4b, 4e, 4f, and 4h induced apoptosis in MiaPaCa2 cells, and compounds 4e, 4f, and 4h induced cell cycle arrest in the G2/M phase. These findings suggest that dolutegravir derivatives are promising candidates for treating MiaPaCa2 tumors.
- Open Access
- 18 June 2025
- Published by Elsevier in Food Chemistry: X
- Vol. 29
Comparative analysis of β-glucan, phenolic compounds, and targeted metabolomics in whole-grain highland barley varieties: Effects of cooking-induced changes
- 18 June 2025
- Published by Elsevier in Food Chemistry: X
- Vol. 29
Open AccessComparative analysis of β-glucan, phenolic compounds, and targeted metabolomics in whole-grain highland barley varieties: Effects of cooking-induced changes
- Open Access
Development of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation
In the context of peptide drug development, glycosylation plays a pivotal role. Accordingly, L-type peptides were synthesized predicated upon the PD-1/PD-L1 blocker DPPA-1. Subsequent glycosylation resulted in the production of two distinct glycopeptides, D-glu-LPPA-1 and D-gal-LPPA-1, by using D-glucose (D-glu) and D-galactose (D-gal), respectively, during glycosylation. Both glycopeptides significantly inhibited the interaction between PD-1 and PD-L1, and the measured half maximal inhibitory concentrations (IC50s) were 75.5 μM and 101.9 μM for D-glu-LPPA-1 and D-gal-LPPA-1, respectively. Furthermore, D-gal-LPPA-1 displayed a pronounced ability to restore T-cell functionality. In an MC38 tumor-bearing mouse model, D-gal-LPPA-1 demonstrated a significant inhibitory effect. Notably, D-gal-LPPA-1 substantially augmented the abundance and functionality of CD8+ T cells in the tumor microenvironment. Additionally, in the lymph nodes and spleens, D-gal-LPPA-1 significantly increased the proportion of CD8+ T cells secreting interferon-gamma (IFN-γ). These strong findings position D-gal-LPPA-1 as a potent enhancer of the antitumor immune response in MC38 tumor-bearing mice, underscoring its potential as a formidable PD-1/PD-L1 blocking agent.
Open AccessDevelopment of Glycosylation-Modified DPPA-1 Compounds as Innovative PD-1/PD-L1 Blockers: Design, Synthesis, and Biological Evaluation
In the context of peptide drug development, glycosylation plays a pivotal role. Accordingly, L-type peptides were synthesized predicated upon the PD-1/PD-L1 blocker DPPA-1. Subsequent glycosylation resulted in the production of two distinct glycopeptides, D-glu-LPPA-1 and D-gal-LPPA-1, by using D-glucose (D-glu) and D-galactose (D-gal), respectively, during glycosylation. Both glycopeptides significantly inhibited the interaction between PD-1 and PD-L1, and the measured half maximal inhibitory concentrations (IC50s) were 75.5 μM and 101.9 μM for D-glu-LPPA-1 and D-gal-LPPA-1, respectively. Furthermore, D-gal-LPPA-1 displayed a pronounced ability to restore T-cell functionality. In an MC38 tumor-bearing mouse model, D-gal-LPPA-1 demonstrated a significant inhibitory effect. Notably, D-gal-LPPA-1 substantially augmented the abundance and functionality of CD8+ T cells in the tumor microenvironment. Additionally, in the lymph nodes and spleens, D-gal-LPPA-1 significantly increased the proportion of CD8+ T cells secreting interferon-gamma (IFN-γ). These strong findings position D-gal-LPPA-1 as a potent enhancer of the antitumor immune response in MC38 tumor-bearing mice, underscoring its potential as a formidable PD-1/PD-L1 blocking agent.
- Open Access
- 8 October 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (10) , 994
Trichoderma hamatum and Its Benefits
Trichoderma hamatum (Bonord.) Bainier (T. hamatum) belongs to Hypocreaceae family, Trichoderma genus. Trichoderma spp. are prominently known for their biocontrol activities and plant growth promotion. Hence, T. hamatum also possess several beneficial activities, such as antimicrobial activity, antioxidant activity, insecticidal activity, herbicidal activity, and plant growth promotion; in addition, it holds several other beneficial properties, such as resistance to dichlorodiphenyltrichloroethane (DDT) and degradation of DDT by certain enzymes and production of certain polysaccharide-degrading enzymes. Hence, the current review discusses the beneficial properties of T. hamatum and describes the gaps that need to be further considered in future studies, such as T. hamatum’s potentiality against human pathogens and, in contrast, its role as an opportunistic human pathogen. Moreover, there is a need for substantial study on its antiviral and antioxidant activities.
- 8 October 2023
- Published by MDPI AG in Journal of Fungi
- Vol. 9 (10) , 994
Open AccessTrichoderma hamatum and Its Benefits
Trichoderma hamatum (Bonord.) Bainier (T. hamatum) belongs to Hypocreaceae family, Trichoderma genus. Trichoderma spp. are prominently known for their biocontrol activities and plant growth promotion. Hence, T. hamatum also possess several beneficial activities, such as antimicrobial activity, antioxidant activity, insecticidal activity, herbicidal activity, and plant growth promotion; in addition, it holds several other beneficial properties, such as resistance to dichlorodiphenyltrichloroethane (DDT) and degradation of DDT by certain enzymes and production of certain polysaccharide-degrading enzymes. Hence, the current review discusses the beneficial properties of T. hamatum and describes the gaps that need to be further considered in future studies, such as T. hamatum’s potentiality against human pathogens and, in contrast, its role as an opportunistic human pathogen. Moreover, there is a need for substantial study on its antiviral and antioxidant activities.
- 1 April 2023
- Vol. 78 (1-4) , 2-5
Novel compounds with promising IDO1 inhibitory activity as new cancer drug candidates: Derivatives of N,N'-diphenylurea linked with 1,2,3-triazole
To explore potential indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, we designed a series of compounds incorporating urea and 1,2,3-triazole structures. IDO1 enzymatic activity experiments with the synthesized compounds were used to verify their molecular-level activity; for instance, the half maximal inhibitory concentra-tion value of compound 3c was 0.07 mu M. Our research has yielded a series of novel IDO1 inhibitors which may be beneficial in the development of drugs targeting IDO1 for cancer treatment.
- 1 April 2023
- Vol. 78 (1-4) , 2-5
Novel compounds with promising IDO1 inhibitory activity as new cancer drug candidates: Derivatives of N,N'-diphenylurea linked with 1,2,3-triazole
To explore potential indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors, we designed a series of compounds incorporating urea and 1,2,3-triazole structures. IDO1 enzymatic activity experiments with the synthesized compounds were used to verify their molecular-level activity; for instance, the half maximal inhibitory concentra-tion value of compound 3c was 0.07 mu M. Our research has yielded a series of novel IDO1 inhibitors which may be beneficial in the development of drugs targeting IDO1 for cancer treatment.
- Open Access
- 1 January 2022
- Published by Walter de Gruyter GmbH in Heterocyclic Communications
- Vol. 28 (1) , 174-180
Design, synthesis, and biological activity of novel pomalidomide linked with diphenylcarbamide derivatives
Based on 2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione as a raw material, a series of novel pomalidomide linked with diphenylcarbamide derivatives were synthesized through several step reactions of substitution, click reaction, and addition reaction. The structures of these compounds were confirmed by 1 H NMR, 13 C NMR, and MS. We discovered that some of the compounds are capable of suppressing indoleamine pyrrole-2,3-dioxygenase-1 activities in in vitro experiments, in which the inhibitory activity of 5b reached the level of benefits.
- 1 January 2022
- Published by Walter de Gruyter GmbH in Heterocyclic Communications
- Vol. 28 (1) , 174-180
Open AccessDesign, synthesis, and biological activity of novel pomalidomide linked with diphenylcarbamide derivatives
Based on 2-(2,6-dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione as a raw material, a series of novel pomalidomide linked with diphenylcarbamide derivatives were synthesized through several step reactions of substitution, click reaction, and addition reaction. The structures of these compounds were confirmed by 1 H NMR, 13 C NMR, and MS. We discovered that some of the compounds are capable of suppressing indoleamine pyrrole-2,3-dioxygenase-1 activities in in vitro experiments, in which the inhibitory activity of 5b reached the level of benefits.